Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2020

Conditions
Intraocular Retinoblastoma
Interventions
DRUG

liposomal vincristine sulfate

Given IV

DRUG

carboplatin

Given IV

DRUG

etoposide

Given IV

Trial Locations (56)

1145

Starship Children's Hospital, Grafton

3052

Royal Children's Hospital, Parkville

4029

Royal Brisbane and Women's Hospital, Herston

6008

Princess Margaret Hospital for Children, Perth

8011

Christchurch Hospital, Christchurch

11201

Brooklyn Hospital Center, Brooklyn

18017

Lehigh Valley Hospital - Muhlenberg, Bethlehem

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

20057

Lombardi Comprehensive Cancer Center at Georgetown University, Washington D.C.

23507

Childrens Hospital-King's Daughters, Norfolk

27710

Duke University Medical Center, Durham

28203

Carolinas Medical Center, Charlotte

33136

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt-Ingram Cancer Center, Nashville

40202

Kosair Children's Hospital, Louisville

40536

University of Kentucky, Lexington

43205

Nationwide Children's Hospital, Columbus

44106

Rainbow Babies and Childrens Hospital, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

45404

The Children's Medical Center of Dayton, Dayton

48202

Wayne State University, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Midwest Children's Cancer Center, Milwaukee

54449

Marshfield Clinic, Marshfield

55455

University of Minnesota Medical Center-Fairview, Minneapolis

55905

Mayo Clinic, Rochester

60612

University of Illinois, Chicago

60614

Childrens Memorial Hospital, Chicago

63110

Washington University School of Medicine, St Louis

64108

The Childrens Mercy Hospital, Kansas City

68114

Children's Hospital and Medical Center of Omaha, Omaha

76104

Cook Children's Medical Center, Fort Worth

76508

Scott and White Memorial Hospital, Temple

77030

Baylor College of Medicine, Houston

M D Anderson Cancer Center, Houston

79410

Covenant Children's Hospital, Lubbock

80045

Children's Hospital Colorado, Aurora

84113

Primary Children's Medical Center, Salt Lake City

85724

University of Arizona Health Sciences Center, Tucson

87106

University of New Mexico Cancer Center, Albuquerque

90027

Children's Hospital Los Angeles, Los Angeles

90242

Southern California Permanente Medical Group, Downey

92123

Rady Children's Hospital - San Diego, San Diego

94143

University of California San Francisco Medical Center-Parnassus, San Francisco

91006-3776

Children's Oncology Group, Arcadia

04074

Maine Children's Cancer Program, Scarborough

21287-8936

Johns Hopkins University, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

R3E 0V9

CancerCare Manitoba, Winnipeg

H3T 1C5

Hospital Sainte-Justine, Montreal

500 034

L V Prasad Eye Institute, Hyderabad

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00335738 - Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma | Biotech Hunter | Biotech Hunter